Publications:

---

Somatic pharmacogenomics of gastrointestinal stromal tumor.

Cancer Drug Resistance (Alhambra, Calif.)

Ravegnini, Gloria G; Hrelia, Patrizia P; Angelini, Sabrina S

Publication Date: 2019

Variant appearance in text: KIT: Y823F

PubMed Link: 35582147

Variant Present in the following documents:

• cdr-2-107.pdf

View BVdb publication page

---

Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases.

Scientific Reports

Šimčíková, Daniela D; Heneberg, Petr P

Publication Date: 2019-12-09

Variant appearance in text: KIT: Y823F

PubMed Link: 31819097

Variant Present in the following documents:

• 41598_2019_54976_MOESM2_ESM.xlsx, sheet 8

View BVdb publication page

---

Tyrosine 842 in the activation loop is required for full transformation by the oncogenic mutant FLT3-ITD.

Cellular And Molecular Life Sciences : Cmls

Kazi, Julhash U JU; Chougule, Rohit A RA; Li, Tianfeng T; Su, Xianwei X; Moharram, Sausan A SA; Rupar, Kaja K; Marhäll, Alissa A; Gazi, Mohiuddin M; Sun, Jianmin J; Zhao, Hui H; Rönnstrand, Lars L

Publication Date: 2017-07

Variant appearance in text: KIT: Y823F

PubMed Link: 28271164

Variant Present in the following documents:

• Main text
• 18_2017_Article_2494.pdf

View BVdb publication page

---

Protein Tyrosine Phosphatase PRL2 Mediates Notch and Kit Signals in Early T Cell Progenitors.

Stem Cells (Dayton, Ohio)

Kobayashi, Michihiro M; Nabinger, Sarah C SC; Bai, Yunpeng Y; Yoshimoto, Momoko M; Gao, Rui R; Chen, Sisi S; Yao, Chonghua C; Dong, Yuanshu Y; Zhang, Lujuan L; Rodriguez, Sonia S; Yashiro-Ohtani, Yumi Y; Pear, Warren S WS; Carlesso, Nadia N; Yoder, Mervin C MC; Kapur, Reuben R; Kaplan, Mark H MH; Daniel Lacorazza, Hugo H; Zhang, Zhong-Yin ZY; Liu, Yan Y

Publication Date: 2017-04

Variant appearance in text: KIT: Y823F

PubMed Link: 28009085

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Distinct cellular properties of oncogenic KIT receptor tyrosine kinase mutants enable alternative courses of cancer cell inhibition.

Proceedings Of The National Academy Of Sciences Of The United States Of America

Shi, Xiarong X; Sousa, Leiliane P LP; Mandel-Bausch, Elizabeth M EM; Tome, Francisco F; Reshetnyak, Andrey V AV; Hadari, Yaron Y; Schlessinger, Joseph J; Lax, Irit I

Publication Date: 2016-08-16

Variant appearance in text: KIT: Y823F

PubMed Link: 27482095

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Allosteric communication across the native and mutated KIT receptor tyrosine kinase.

Plos Computational Biology

Laine, Elodie E; Auclair, Christian C; Tchertanov, Luba L

Publication Date: 2012

Variant appearance in text: KIT: Y823F

PubMed Link: 22927810

Variant Present in the following documents:

• Main text
• pcbi.1002661.pdf

View BVdb publication page

---